The Azithromycin for Oral Suspension, cataloged under National Stock Number 6505-01-455-4546, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Teva Pharmaceuticals Usa, Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-455-4546 |
| Primary Part Number | NDC00093-2027-23 |
| Item Name | Azithromycin for Oral Suspension |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Teva Pharmaceuticals Usa, Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 300.000 MILLIGRAMS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Physical Form | POWDER |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00093-2027-23 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| Reference | Meaning |
|---|---|
| 98-0305 | 5/1 Secondary reference Defense Medical Standardization Board |
| NDC00069-3110-19 | 3/9 Design control — primary reference Pfizer Laboratories Div of Pfizer Inc |
| ZITHROMAX | 5/1 Secondary reference Pfizer Laboratories Div of Pfizer Inc |
NSN 6505-01-455-4546 is a Azithromycin for Oral Suspension, manufactured by Teva Pharmaceuticals Usa, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-455-4546 has 1 manufacturer part number on file: NDC00093-2027-23 (Teva Pharmaceuticals Usa, Inc.).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-505-3359. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00093-2027-23: Primary Container Content Quantity: 300.000 MILLIGRAMS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Physical Form: POWDER. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.